HomepageBlogAGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More Blog AGC Plans to Invest Over 200B Yen in CDMO Operations for Gene & Cell Therapy, More admin Posted on August 14, 2023 AGC Inc. (TYO:5201) is looking to invest more than 200 billion yen ($1.7 billion) into CDMO operations by 2025. Plans…… Please subscribe to read the full story. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Post navigation Next PostChemical Innovation: Unveiling the Dynamics of Japan’s Thriving Chemical Industry You Might Also Like Blog IHI Speeds up Development of Several Ammonia-Based Technologies admin August 14, 2023 Blog Sumitomo Chemical Focuses on Garnet Structure in Solid-State Battery Development admin August 14, 2023 Blog Mitsui Chemicals Plans to Beef up Infrastructure for Lens Monomer Production admin August 14, 2023 Blog Column: China’s “Dual Carbon” Target Creates Waves in Chemical Sector admin August 14, 2023
Blog Sumitomo Chemical Focuses on Garnet Structure in Solid-State Battery Development admin August 14, 2023
Blog Mitsui Chemicals Plans to Beef up Infrastructure for Lens Monomer Production admin August 14, 2023
From Chemistry to Energy: Unveiling the Integral Role of Chemical Reactions in Power Generation September 30, 2023